Using scRNA-seq data from 27 lung cancer patients, we identified expression levels of SIRPG in different cell subtypes and found SIRPG was mainly expressed in T cells, especially CD8+ Tex and CD4+ Tregs. Here, SIRPG is linked to lung carcinoma.